Skip to main content
Caplight Logo









Seismic

Seismic

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://seismictx.com/

Last Round

Series B

Dec 4, 2023

Total Funding Raised

$222M

Company Overview

Seismic Therapeutic is a biotechnology company that leverages machine learning to enhance the immunology drug development process, addressing key challenges in biologics discovery to facilitate the creation of innovative and efficient medicines for patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryimmunologyprotein engineeringai drug discoveryin silico drug designautoimmune diseasebifunctional antibodystructural biologymachine learningbiologicsprecision medicineai biotechtherapeutic pipelineclinical stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Seismic Comparables

Compare Seismic with similar companies based on industry and business-model similarity.

Seismic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Peptone
81%
Generate Biomedicines
81%
AbSci
77%

Seismic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 4, 2023
Series AFeb 9, 2022

Key People

Founding team and executive leadership

Nathan Higginson-Scott

Chief Technology Officer And SVP, Drug Creation

Executive Team

John Sundy

Chief Medical Officer and Head of R&D

Executive Team

Seismic Investors

Notable investors and investment history

Seismic investors
InvestorRounds
Boxer CapitalSeries B, Series A
Codon CapitalSeries B
GVSeries B, Series A
GaingelsSeries B
Amgen VenturesSeries B
SamanthaSeries B
Alexandria Venture InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 15, 2026

    Presenting at the 44th Annual J.P. Morgan Healthcare Conference.

  • Jun 2, 2025

    Sophie Jones appointed as the new Chief Financial Officer.

Seismic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Seismic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Seismic's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range44
Year Founded2020
Last FundingDec 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?